Navigation Links
Law Office of Brodsky & Smith, LLC Announces Settlements of Yaz, and Yasmin Cases
Date:8/2/2012

BALA CYNWYD, Pa., Aug. 2, 2012 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against Bayer AG ("Bayer") (XETRA- BAYN.DE) and Barr Laboratories, Inc. ("Barr"") on behalf of individuals that suffered an adverse side effect while taking Yaz or Yasmin, and their generic version Ocella, such as blood clots, deep vein thrombosis, strokes, or a heart attacks.

Bayer has announced that it has reached agreements to settle cases with a total of 1,877 claimants that used these combinational oral contraceptives that contained both estrogen and progestins not found in other oral contraceptives. Bayer has also reported that there are 13,530 claimants remaining that they currently know of in the U.S. and that they expect both the number of claimants and settled cases to continue to grow. On April 10, 2012, the US Food and Drug Administration announced that Bayer's Yaz birth-control pill and similar medications may carry a higher risk of blood clots than other pills.  

If you or a family member have suffered a serious injury or a loved one died after taking Yaz, Yazmin, or Ocella and you wish to discuss the legal ramifications of these settlements or your right to obtain compensation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions.  You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at investorrelations@brodsky-smith.com, or by calling toll free 877-LEGAL-90.

 


'/>"/>
SOURCE Brodsky & Smith, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. RxAlly Strengthens Leadership Team With New Chief Information Officer Mike Groh
2. Insmed Announces Planned Departure Of Chief Financial Officer
3. Quanterix Appoints Paul Chapman as President and Chief Executive Officer
4. Celladon Corporation Receives Patent from United States Patent and Trademark Office
5. Hologic and Gen-Probe Announce Clearance from German Federal Cartel Office for Hologics Acquisition of Gen-Probe
6. HeartWare Names Peter F. McAree Chief Financial Officer
7. Merz, Inc. Announces Promotion of Katrina Church to Vice President, Chief Compliance Officer
8. KannaLife Sciences, Inc. Signs Exclusive License Agreement with National Institutes of Health Office of Technology Transfer (NIH-OTT)
9. Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
10. Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.
11. Tara Dall, MD Joins Health Diagnostic Laboratory (HDL, Inc.) as Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... 5, 2016 Special purpose needles are used in ... fluid and cells from organs or lumps and are available ... The global market for special purpose needles is showing a ... of revenue, the global special purpose needles market is projected ... period (2016–2026) and is expected to be valued at US$ ...
(Date:12/5/2016)... Dec. 5, 2016  Pennsylvania Physician General Dr. ... Programs Gary Tennis today filled prescriptions for ... Pharmacy in York to demonstrate ... Dr. Levine as a prescription to acquire naloxone at ... important to remember that any Pennsylvanian can walk up ...
(Date:12/5/2016)... -- Research and Markets has announced the addition ... (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research ... report to their offering. ... , The western blotting ... USD 574.8 Million in 2016, growing at a CAGR of 4.9%. ...
Breaking Medicine Technology:
(Date:12/6/2016)... ... 06, 2016 , ... U.S. Security Associates (USA) was named ... their industry leading training methods that engage their associates and link their achievements ... elite in employer-sponsored training and development programs. , “The 2017 Training Top 125 ...
(Date:12/5/2016)... ... ... For many years, Andrew G. Zubinas has accumulated over 130 hardcover ... Lithuanian language and its poetry inspired him in writing “ Forest Lungs ... aspects of a living, breathing forest where nothing ever stays the same. His subjects ...
(Date:12/5/2016)... ... 05, 2016 , ... “Epilepsy Awareness,” which can be found ... a conversation about epilepsy, bearing down on the social stigma and lack of ... with epilepsy within their lifetime. With such a large percentage of people affected, ...
(Date:12/5/2016)... , ... December 05, 2016 , ... BSI and Brenntag ... United States and Canada for distribution of their natural fruits and beverage ... is an exciting addition to our Life Sciences product portfolio,” said Steve Brauer, ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... portfolio company, today announced it has acquired the assets of Frankfurt, Germany ... a subsidiary of Chiltern International and focuses on clinical trial drug packaging, ...
Breaking Medicine News(10 mins):